Prevalence and correlates of apathy in myotonic dystrophy type 1

BackgroundApathy in DM1 has long been acknowledged in clinical practice. However, a major drawback is that the concept has been only sparsely explored in previous specific studies. This study aimed to determine the prevalence of apathy in myotonic dystrophy (DM1), to compare it with facioscapulohumeral dystrophy (FSHD) patients and normal healthy controls, and explore its relationship to psychopathological features and cognitive function.MethodsLevels of apathy in 38 DM1 patients with adult phenotypes were compared with 19 patients with FSHD and 20 matched controls. Patient participants were consecutively recruited, regarding their interdisciplinary annual evaluation at the neuromuscular pathology reference center (Institute of Myology, Paris, France), within an 18-month period. Additional measurements included motor disability, fatigue, depression, anxiety, and cognitive abilities. Inter-group comparisons were performed using non-parametric Kruskal-Wallis tests and Mann–Whitney U Tests. Intra-group comparisons were carried out with the Wilcoxon Signed rank and Friedman tests. Also, Spearman’s correlations were used to assess the strength of linear relationships between pairs of variables. The significance level was set at 0.05.ResultsGlobal score of apathy was significantly higher in DM1 patients than in FSHD patients (p < 0.01) and in controls (p < 0.001). Sixteen of 38 DM1 patients (39.5 %) met the criterion for apathy, contrasting with only 4 of the 19 (21.1 %) FSHD patients. No control subject was apathetic. Moreover, apathy in DM1 patients was negatively correlated to MMSE (r = −.46, p < .05) and Stroop Word (r = −.55, p < .01) scores, but not with age, educational level, disease duration, CTG repeats, motor functional disability, fatigue, depression, and anxiety.ConclusionsApathy is a frequent symptom in DM1 (almost 40 %). It is more prevalent than in a similarly disabled group of patients with FSHD and in controls. Results also show that apathy in DM1 is independent of the psychopathological domain, fatigue, age, and motor disability, but associated to general cognitive status. These results altogether could suggest a central cause for apathy in DM1 rather than an adjustment process to cope with the progressive and debilitating nature of the disease. Data emphasize the importance to evaluate this symptom in routine clinical management of DM1 patients.

[1]  David E. Housman,et al.  Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member , 1992, Cell.

[2]  D. Roger,et al.  Self-Evaluation Questionnaire , 2014 .

[3]  R. Hales,et al.  J Neuropsychiatry Clin Neurosci , 1992 .

[4]  W. Reardon,et al.  Size of the unstable CTG repeat sequence in relation to phenotype and parental transmission in myotonic dystrophy. , 1993, American journal of human genetics.

[5]  Jane S. Paulsen,et al.  Apathy is not depression. , 1998, The Journal of neuropsychiatry and clinical neurosciences.

[6]  A. López de Munain,et al.  Cognitive function in facioscapulohumeral dystrophy correlates with the molecular defect , 2009, Genes, brain, and behavior.

[7]  M. Ghilardi,et al.  Apathy, but Not Depression, Reflects Inefficient Cognitive Strategies in Parkinson's Disease , 2011, PloS one.

[8]  Christie Golden,et al.  Stroop Color and Word Test: Manual for Clinical and Experimental Uses. , 1978 .

[9]  P Sockeel,et al.  The Lille apathy rating scale (LARS), a new instrument for detecting and quantifying apathy: validation in Parkinson’s disease , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[10]  D. Royall,et al.  The FAB: A frontal assessment battery at bedside , 2001, Neurology.

[11]  H. Reichmann,et al.  Modafinil for excessive daytime sleepiness in myotonic dystrophy , 2001, Neurology.

[12]  C. Spielberger,et al.  Manual for the state-trait anxiety inventory (form Y) : "self-evaluation questionnaire" , 1983 .

[13]  L. Defebvre,et al.  Characteristics of apathy in Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[14]  P W Burgess,et al.  Strategy application disorder: the role of the frontal lobes in human multitasking , 2000, Psychological research.

[15]  C. Longman,et al.  Modafinil for excessive daytime sleepiness in myotonic dystrophy type 1 – The patients’ perspective , 2012, Neuromuscular Disorders.

[16]  A. Damasio,et al.  Emotion, decision making and the orbitofrontal cortex. , 2000, Cerebral cortex.

[17]  M. Åsberg,et al.  A New Depression Scale Designed to be Sensitive to Change , 1979, British Journal of Psychiatry.

[18]  R Jouvent,et al.  Psychopathological and emotional deficits in myotonic dystrophy , 1998, Journal of neurology, neurosurgery, and psychiatry.

[19]  G. Tedeschi,et al.  Does abnormal neuronal excitability exist in myotonic dystrophy)?¶II. Effects of the antiarrhythmic drug hydroquinidine on apathy and hypersomnia , 2000, Neurological Sciences.

[20]  E. Nanba,et al.  [Myotonic dystrophy]. , 2005, Nihon rinsho. Japanese journal of clinical medicine.

[21]  Karl Rohrer über Myotonia atrophica (Dystrophia myotonica) , 1916, Deutsche Zeitschrift für Nervenheilkunde.

[22]  B. Eymard,et al.  Cognitive profile in childhood myotonic dystrophy type 1: Is there a global impairment? , 2007, Neuromuscular Disorders.

[23]  G. Meola,et al.  Cerebral involvement in myotonic dystrophies , 2007, Muscle & nerve.

[24]  J. Clément,et al.  Family, Alzheimer's disease and negative symptoms , 2001, International journal of geriatric psychiatry.

[25]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[26]  T. Tombaugh Trail Making Test A and B: normative data stratified by age and education. , 2004, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[27]  D. Gaudet,et al.  Health supervision and anticipatory guidance in adult myotonic dystrophy type 1 , 2010, Neuromuscular Disorders.

[28]  J. Ridley Studies of Interference in Serial Verbal Reactions , 2001 .

[29]  D. Perani,et al.  Executive dysfunction and avoidant personality trait in myotonic dystrophy type 1 (DM-1) and in proximal myotonic myopathy (PROMM/DM-2) , 2003, Neuromuscular Disorders.

[30]  Luc Noreau,et al.  Predictors of disrupted social participation in myotonic dystrophy type 1. , 2008, Archives of physical medicine and rehabilitation.

[31]  D. Rubinsztein,et al.  Apathy and hypersomnia are common features of myotonic dystrophy , 1998, Journal of neurology, neurosurgery, and psychiatry.

[32]  R. Levy,et al.  Apathy and the basal ganglia , 2006, Journal of Neurology.

[33]  P. Harper,et al.  Genetic risks for children of women with myotonic dystrophy. , 1991, American journal of human genetics.

[34]  C. Spielberger Manual for the State-Trait Anxiety Inventory (STAI) (Form Y , 1983 .

[35]  R. Robinson,et al.  A prospective longitudinal study of apathy in Alzheimer’s disease , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[36]  L. Defebvre,et al.  The Lille Apathy Rating Scale: Validation of a caregiver‐based version , 2008, Movement disorders : official journal of the Movement Disorder Society.

[37]  R. Marin,et al.  Reliability and validity of the apathy evaluation scale , 1991, Psychiatry Research.

[38]  N. Larocca,et al.  The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. , 1989, Archives of neurology.

[39]  J. Emparanza,et al.  Cognitive/personality pattern and triplet expansion size in adult myotonic dystrophy type 1 (DM1): CTG repeats, cognition and personality in DM1 , 2009, Psychological Medicine.

[40]  A. Cruz-Martínez Myotonic Dystrophy: Present Management, Future Therapy, First edition, Peter S. Harper, Baziel van Engelen, Bruno Eymard, Douglas E. Wilcox (Eds.). Oxford University Press, New York (2004), 251 pages, ISBN: 0-19-852782-9 , 2005 .

[41]  J. Borod The Neuropsychology of emotion , 2000 .

[42]  L. Samuelsson,et al.  Depression in Myotonic Dystrophy type 1: clinical and neuronal correlates , 2010, Behavioral and Brain Functions.

[43]  M. Van der Linden,et al.  Apathy and Executive Dysfunction in Alzheimer Disease , 2010, Alzheimer disease and associated disorders.

[44]  S. Hansen,et al.  Behavioral and Brain Functions , 2006 .

[45]  Kelly J. Murphy,et al.  Differentiation of states and causes of apathy. , 2000 .

[46]  D. Sheehan,et al.  DSM-IH-R Psychotic Disorders: procedural validity of the Mini International Neuropsychiatric Interview (MINI). Concordance and causes for discordance with the CIDI , 1998, European Psychiatry.

[47]  S. Hansen,et al.  Temperament and character in patients with classical myotonic dystrophy type 1 (DM-1) , 2005, Neuromuscular Disorders.

[48]  C. Spielberger,et al.  Manual for the State-Trait Anxiety Inventory , 1970 .

[49]  Caroline Knight,et al.  Ecological validity of a simplified version of the multiple errands shopping test. , 2003, Journal of the International Neuropsychological Society : JINS.

[50]  N. Larocca,et al.  Application to Patients With Multiple Sclerosis and Systemic Lupus Erythematosus , 2016 .